Furthermore, Chang and colleagues found that METTL3 was highly expressed in IDH wild-type gliomas, and the high expression of METTL3 was positively correlated with higher tumour malignancy and poor prognosis. The gene discussed is METTL3; the disease is central nervous system cancer.